pharma · Acne Vulgaris · Plasmodium Falciparum Malaria · ATXI
AVENUE THERAPEUTICS
AVENUE THERAPEUTICS, INC.
Avenue Therapeutics is a pharma organization headquartered in Bay Harbor Islands, USA. It trades on NYSE under ticker ATXI. Primary therapeutic focus areas include Acne Vulgaris, Plasmodium Falciparum Malaria, Neural Inh
Bay Harbor Islands, USA HQ
10 Employees
Public company Type
ATXI · NYSE Ticker
Company details
- Status
- Public
- HQ
- Bay Harbor Islands, USA
- Employees
- 10
- Programs
- 4
- Drugs
- 8
- Patents
- 1
Artemether-lumefantrine
Phase 3 · small molecule · Plasmodium Falciparum Malaria
Artemether-lumefantrine for Plasmodium Falciparum Malaria is a Phase 3 program (small_molecule) at AVENUE THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code CCOA566A2403
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AVENUE THERAPEUTICS, INC.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Plasmodium Falciparum Malaria
- Status
- completed
- Trials
- 1